Skip to content

Evaluation of the DocWeight 2.3-program for the behavioral treatment of obesity

Evaluation of the DocWeight 2.3-program for the behavioral treatment of obesity - DocWeight2.3

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00031172
Enrollment
240
Registered
2023-04-24
Start date
2023-08-21
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E65-E68

Interventions

Group 1: Participation in DocWeight2.3 (without meal replacement) DocWeight 2.3 is divided into a start phase, which takes place 8 to 2 weeks before the start of the course, three therapy phases (orie

Sponsors

Universität Leipzig
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: - BMI of 30 - 50 kg/m² - Sufficient German language skills - Written declaration of consent - Performance of an ergometry (bicycle or treadmill) with a load capacity of at least 75 W for at least 2 min.

Exclusion criteria

Exclusion criteria: - Participation in another weight loss program, including use of prescribed weight loss apps (DiGAs) - Severe (acute or chronic) medical condition a. Type 1 diabetes mellitus, pancreopriver diabetes mellitus without residual pancreatic function b. Type 2 diabetes mellitus with intensified insulin therapy (type 2 diabetes mellitus with oral therapy only, with GLP-1 analog therapy (without change in dosage in the last 3 months), or with BOT (basal-assisted oral therapy with long-acting insulin) is not an exclusion criterion) c. Inadequately controlled hypertension (RR >160/95 mmHg; if this threshold is exceeded in the screening examination, a 24 h RR measurement can be performed and if here the mean RR over 24 h is 3-fold above the upper reference range) g. Alcohol dependence and current use of other drugs (e.g., cannabis, cocaine, crystal, etc.) h. acute infection i. untreated endocrine disease (e.g., hypothyroidism). - Severe or untreated psychiatric illness that makes regular participation in the program impossible - New prescription or dose change of weight-increasing or weight-lowering medications within the 3 months prior to study inclusion; if this occurs after inclusion during the study intervention already in progress, subjects will be excluded from the analysis - Significant limitation in physical mobility, such that participation in exercise classes is limited or not possible at all - Major weight change (=10% of body weight) in the previous 3 months - Participation in another clinical trial - Existing pregnancy or breastfeeding

Design outcomes

Primary

MeasureTime frame
The change in body weight after 12 months (in kg and % of initial weight). The weight is collected without shoes, but clothed. 1 kg is deducted for clothing.

Secondary

MeasureTime frame
Waist circumference, cardiovascular risk factors, quality of life, body composition, physical performance ability, nutritional behavior

Countries

Germany

Contacts

Public ContactSarah Victoria Frenzel

Universität Leipzig

sarahvictoria.frenzel@medizin.uni-leipzig.de+493419722926

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026